Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint
evaluation (PROBE) parallel group study in subjects with confirmed VTE. This study is
designed to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban and to
compare the efficacy and safety of edoxaban against standard of care in pediatric subjects
with confirmed VTE.